Filing search / Inhibrx Biosciences, Inc. / "Leadership"

DEFA14A

INBX Inhibrx Biosciences, Inc.

23 Jan 24

Additional proxy soliciting materials

5:25pm

in the transition services provided by New Inhibrx. Q5: Will we be updated by managers and leadership as the Spin-Off and Closing approach? A5: We will provide … updates to Inhibrx employees as we have pertinent information to share. Additional meetings with managers and leadership will be scheduled as needed

8-K

EX-99.2

INBX Inhibrx Biosciences, Inc.

7 Aug 23

Inhibrx Reports Second Quarter 2023 Financial Results

4:05pm

in 2010 Company overview Partnerships with Industry Leaders: 165+ employees with an experienced leadership team and a deep expertise in protein

8-K

EX-99.1

INBX Inhibrx Biosciences, Inc.

16 Nov 22

Regulation FD Disclosure

9:01am

+ Smaller than conventional antibodies + Antibody-like PK profile + Readily manufactured at high yields using standard processes Experienced leadership

8-K

EX-99.1

piz2re11oq uk6snp

4 Oct 22

Entry into a Material Definitive Agreement

8:02am

8-K

EX-99.1

unq5ps1w2op8d9z

10 Aug 22

Regulation FD Disclosure

4:06pm

8-K

EX-99.1

0kxdphn7

30 Jun 22

Regulation FD Disclosure

9:01am

8-K

EX-99.1

v3zi bjig3rvn2v2f6y

16 May 22

Regulation FD Disclosure

9:03am

8-K

EX-99.1

pa3m9vnhfj5f x6

4 Apr 22

Regulation FD Disclosure

4:06pm

8-K

EX-99.2

nexi szrea1

4 Jan 22

Regulation FD Disclosure

4:41pm

8-K

EX-99.1

uf0wrj 3fu0p78i8yc

28 Oct 21

Departure of Directors or Certain Officers

8:50am

8-K

EX-99.2

g8el868t

12 Oct 21

Regulation FD Disclosure

7:50am

8-K

EX-99.2

gg31dvj4yv36bes3

21 Jun 21

Entry into a Material Definitive Agreement

4:05pm

DEF 14A

6kv58ni5zknuoixa

28 Apr 21

Definitive proxy

7:51am

8-K

EX-99.2

bmqf48hlf7bmlwd0c 35

12 Mar 21

Results of Operations and Financial Condition

8:55am

10-K

cjrtp80w ljc8hg

12 Mar 21

Annual report

8:46am

8-K

EX-99.2

m7gw1

5 Jan 21

Inhibrx Announces Phase 1 Dose Escalation Results of

12:00am